Search results
Fauci’s memoir reveals clashes with Trump, other private moments - The Boston Globe
The Boston Globe· 1 day agoThe president’s anger had been stirred by Fauci’s interview with The Washington Post, in which the...
KRX Growth Leaders With High Insider Ownership June 2024
Simply Wall St. via Yahoo Finance· 1 day agoFollowing a brief retreat from its four-day winning streak, the South Korean stock market remains a...
A Study Allegedly Found Some Bandage Brands Contain PFAS 'Forever Chemicals.' We Checked the...
Snopes via Yahoo News· 1 day agoPerfluorooctanoic acid (PFOA), the most well-studied PFAS, is classified as a human carcinogen. PFAS...
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
The Mammoth Times· 6 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs ...
Establishing Commercial Manufacturing Services For Antibody-Drug Conjugates
BioresearchOnline· 7 days agoAntibody-drug conjugates (ADCs) are complex, potent biologics that offer significant potential to...
What Happens to Your Body When You Take Colostrum Powder
Eating Well via Yahoo News· 5 days agoInfluencers on TikTok may be encouraging you to try this latest trend. But should you? Getty Images...
What are the symptoms of Lyme disease? It's a broad range.
USA Today· 1 day agoThe typical symptoms associated with long COVID-19, like brain fog, dizziness and fatigue are...
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
MedPage Today· 5 days agoCombining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with the standard backbone of...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoELREXFIO is a B-cell maturation antigen (BCMA)-cluster of differentiation (CD)3-directed bispecific ...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 5 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...